179 related articles for article (PubMed ID: 203543)
1. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
Takeichi N; Boone CW; Holden HT; Herberman RB
Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
Murasko DM; Prehn RT
J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
[TBL] [Abstract][Full Text] [Related]
3. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
Basombrío MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
4. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
Levy JP; Leclerc JC
Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
[No Abstract] [Full Text] [Related]
5. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
Harada M; Pearson G; Redmon L; Winters E; Kasuga S
J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
[TBL] [Abstract][Full Text] [Related]
6. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
Epstein LB; Knight RA
Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
[TBL] [Abstract][Full Text] [Related]
7. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
[TBL] [Abstract][Full Text] [Related]
8. Isotype distribution and specificity of the antibody response to primary Moloney murine sarcoma virus infection in BALB/c mice.
Powell TJ; Gaupp B; Epps JM; Srinivas RV; Lamon EW
Viral Immunol; 1989; 2(2):89-101. PubMed ID: 2673279
[TBL] [Abstract][Full Text] [Related]
9. Moloney sarcoma virus-induced tumors in athymic (nude) mice: growth pattern and antibody responses.
Davis S
J Natl Cancer Inst; 1975 Mar; 54(3):793-4. PubMed ID: 164570
[TBL] [Abstract][Full Text] [Related]
10. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
Becker S; Haskill S
J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
12. Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.
Weiland E; Mussgay M
Arch Virol; 1980; 66(1):1-10. PubMed ID: 7436738
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Moloney murine sarcoma and leukemia virus complex as a model for airborne oncogenic virus biohazards: survival of airborne virus and exposure of mice.
Hinshaw VS; Schaffer FL; Chatigny MA
J Natl Cancer Inst; 1976 Oct; 57(4):775-8. PubMed ID: 187776
[TBL] [Abstract][Full Text] [Related]
14. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
Gomard E; Leclerc JC; Levy JP
J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
[No Abstract] [Full Text] [Related]
15. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
Lamon EW; Powell TJ; Walia AS; Lidin BI; Srinivas RV; Baskin JG; Kearney JF
J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
[TBL] [Abstract][Full Text] [Related]
16. Lack of M-MuSV tumour regression associated with T lymphocyte tolerance.
Chieco-Bianchi L; Collavo D; Zanovell P; De Rossi A; Davies AJ
Nature; 1980 Jun; 285(5767):667-8. PubMed ID: 6248790
[No Abstract] [Full Text] [Related]
17. Role of infectious virus expression and immune response in retrovirus-induced oncogenesis.
Zanovello P; D'Andrea E; Ronchese F; De Rossi A; Collavo D; Chieco-Bianchi L
Tumori; 1984 Feb; 70(1):1-8. PubMed ID: 6324431
[TBL] [Abstract][Full Text] [Related]
18. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
[No Abstract] [Full Text] [Related]
19. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
20. Transformation of horse skin cells by type-C sarcoma viruses.
Rhim JS; Ro HS; Kim EB; Gilden RV; Huebner RJ
Int J Cancer; 1975 Feb; 15(2):171-9. PubMed ID: 165152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
